Total Funding
41
16
Total FundingVenture - Series Unknown raised
Growth Score 41 in past quarter
-3 pts
Heat Score 16 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1195628
One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's
Yigal Stav: Co-Founder & CEOPast Role: MoreVC, Venture Partner
Yissum Technology Transfer Company of the Hebrew University
About the Company
One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's ability to recruit blood vessels from the neighboring tissue. Angiogenesis, the process by which new blood vessels are formed, is a hallmark capability of cancer, critical for the development of all solid
tumors. This property is the basis for anti-angiogenic therapy, a promising novel strategy for treatment of cancer.
